Empower LCS/Call+ for Lung Cancer Screening
(Empower LCS+ Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to boost lung cancer screening rates using new strategies, such as educational materials and reminders. It targets individuals who qualify for lung cancer screening based on guidelines, specifically those who have smoked for many years and either continue to smoke or have quit recently. Participants will receive either usual care with brochures or additional support through the Empower LCS/Call+ program, a telephone navigation service. The trial will evaluate whether these methods increase screening rates and determine the most effective approach. If lung cancer screening remains incomplete after the initial steps, additional phone support will help overcome any obstacles. As an unphased trial, this study provides a unique opportunity to enhance lung cancer screening strategies for future patients.
What prior data suggests that the Empower LCS/Call+ intervention is safe for lung cancer screening?
Research has shown that the Empower LCS/Call+ program, which provides phone support, is easy for patients to manage. Studies have found that participants using this program for lung cancer screening experience no major side effects. This indicates the program's safety for those considering joining a clinical trial. The program aims to help individuals complete their lung cancer screenings without causing harm or discomfort.12345
Why are researchers excited about this trial?
Researchers are excited about the Empower LCS/Call+ trial because it aims to enhance lung cancer screening participation through unique methods. Unlike the usual care, which typically involves standard education and reminders, the Empower LCS/Call+ approach offers telephone navigation specifically for those who do not initially respond. This personalized, proactive outreach could significantly increase screening rates, leading to earlier detection of lung cancer when it's most treatable. By potentially improving participation in lung cancer screenings, this method could transform current practices and lead to better outcomes for patients.
What evidence suggests that the Empower LCS/Call+ intervention could be effective for improving lung cancer screening?
Research has shown that the Empower LCS/Call+ program, tested in this trial, can increase lung cancer screening rates. Participants may receive the Empower LCS/Call+ intervention, which includes patient navigation. This component significantly boosts the number of completed lung cancer screenings. For example, one study found that navigation increased screening rates in underserved communities. Additionally, Empower LCS helps patients understand the risks and benefits of lung cancer, leading to more discussions and completed screenings. Overall, this approach aims to make lung cancer screening easier and more effective for those who need it most.12346
Who Is on the Research Team?
Ilana Graetz, PhD
Principal Investigator
Emory University
Gelareh Sadigh
Principal Investigator
University of California, Irvine
Are You a Good Fit for This Trial?
This trial is for adults who are eligible for lung cancer screening based on current U.S. guidelines, typically people with a history of heavy smoking and within certain age ranges. Participants will be recruited from UC Irvine Health and Emory Healthcare.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Survey
Participants complete a baseline survey to assess initial knowledge and attitudes towards lung cancer screening
Intervention
Participants receive either enhanced usual care or the Empower LCS/Call+ intervention, which includes educational materials, reminders, and information about resources
Follow-up Surveys
Participants complete follow-up surveys to assess changes in knowledge, attitudes, and screening behaviors
Follow-up
Participants are monitored for completion of lung cancer screening and other outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Call+ Telephone Navigation
- Empower LCS
Trial Overview
The study compares usual care to an intervention called Empower LCS/Call+, which includes educational materials, reminders, resource information, and extra phone support to help patients complete lung cancer screening. Participants are randomly assigned to each group.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Empower LCS with Call+ offered to non-responders
Usual care + educational brochure
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, Irvine
Lead Sponsor
Citations
Empowering Patients' Lung Cancer Screening Uptake ...
The results of this study will help determine the feasibility, acceptability, and preliminary effectiveness of the Empower LCS/Call+ ...
Effect of Patient Navigation on Completion of Lung Cancer ...
Specifically, navigation may improve rates of screening and follow-up for abnormal results; it can also decrease disparities in care, particularly for breast ...
3.
ctv.veeva.com
ctv.veeva.com/study/empowering-patients-lung-cancer-screening-uptake-empower-lcs-callEmpowering Patients' Lung Cancer Screening Uptake ...
The results of this study will help determine the feasibility, acceptability, and preliminary effectiveness of the Empower LCS/Call+ ...
A Single-Arm Pilot Feasibility Clinical Trial
Results In all, 70 patients enrolled. Empower LCS targets patients' lung cancer perceived risk, severity, and perceived LCS benefits through ...
Empowering Patients' Lung Cancer Screening Uptake ...
The results of this study will help determine the feasibility, acceptability, and preliminary effectiveness of the Empower LCS/Call+ ...
Tele-Navigation for Lung Cancer Screening
Studies have found that phone-based guidance increases the likelihood of patients completing their screening without major side effects, indicating the program ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.